R. David Hoover - May 28, 2021 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Director
Signature
/s/ Jinee L. Majors, as Attorney-in-Fact for R. David Hoover
Stock symbol
ELAN
Transactions as of
May 28, 2021
Transactions value $
$15,500
Form type
4
Date filed
6/2/2021, 04:53 PM
Previous filing
May 12, 2021
Next filing
Jul 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ELAN Common Stock 32K May 28, 2021 Direct F1
holding ELAN Common Stock 80K May 28, 2021 Revocable Trust F1
holding ELAN Common Stock 15.9K May 28, 2021 Suzanne A. Hoover Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Deferred Stock Units Award $15.5K +431 +2.8% $35.98 15.8K May 28, 2021 Common Stock 431 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Change of 10,000 shares to indirect ownership of shares previously reported as directly owned by the reporting person.
F2 Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
F3 The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
F4 The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021.

Remarks:

Chairman of the Elanco Board of Directors